Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von GraveDigger 

Hims & Hers Health Inc. diskutieren

Hims & Hers Health Inc.

WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Aktie / ? /

23,97 €
-0,17 %

Buy Hims & Hers Health Inc.

Einschätzung Buy
Rendite (%) 12,73 %
Kursziel 14,12
Veränderung
Endet am 28.02.24

Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $15.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 158,85 %
Kursziel 9,99
Veränderung
Endet am 28.07.24

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $11.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 79,13 %
Kursziel 12,78
Veränderung
Endet am 08.08.24

Hims & Hers Health, Inc. (NYSE: HIMS) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $14.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 249,74 %
Kursziel 13,65
Veränderung
Endet am 05.01.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Tigress Financial from $14.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 208,38 %
Kursziel 14,74
Veränderung
Endet am 27.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $12.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 208,38 %
Kursziel 15,66
Veränderung
Endet am 27.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 263,61 %
Kursziel 14,77
Veränderung
Endet am 28.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 82,35 %
Kursziel 18,55
Veränderung
Endet am 10.04.25

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Seaport Res Ptn.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 162,96 %
Kursziel 20,28
Veränderung
Endet am 03.06.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $17.25 to $22.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 120,36 %
Kursziel 24,19
Veränderung
Endet am 13.06.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $22.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 110,01 %
Kursziel 23,00
Veränderung
Endet am 11.07.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at TD Cowen from $15.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 145,06 %
Kursziel 21,54
Veränderung
Endet am 22.08.25

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 215,83 %
Kursziel 18,04
Veränderung
Endet am 13.09.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target lowered by analysts at Bank of America Co. from $24.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 156,11 %
Kursziel 21,09
Veränderung
Endet am 14.10.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $20.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Der Beitrag wird untersucht

Einschätzung Buy
Rendite (%) 107,35 %
Kursziel 23,02
Veränderung
Endet am 21.10.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $23.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 71,41 %
Kursziel 26,17
Veränderung
Endet am 08.11.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at TD Cowen from $25.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.
Ratings data for HIMS provided by MarketBeat